Correction to: ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma

Affiliations

Weipu Mao: Department of Urology, Affiliated Zhongda Hospital of Southeast University
Keyi Wang: Department of Urology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University
Bin Xu: Department of Urology, Affiliated Zhongda Hospital of Southeast University
Hui Zhang: Department of Anesthesiology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University
Si Sun: Department of Urology, Affiliated Zhongda Hospital of Southeast University
Qiang Hu: Department of Urology, Affiliated Zhongda Hospital of Southeast University
Lei Zhang: Department of Urology, Affiliated Zhongda Hospital of Southeast University
Chunhui Liu: Department of Urology, Affiliated Zhongda Hospital of Southeast University
Shuqiu Chen: Department of Urology, Affiliated Zhongda Hospital of Southeast University
Jianping Wu: Department of Urology, Affiliated Zhongda Hospital of Southeast University
Ming Chen: Department of Urology, Affiliated Zhongda Hospital of Southeast University
Wei Li: Department of Urology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University
Bo Peng: Department of Urology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University

Abstract

An amendment to this paper has been published and can be accessed via the original article.

ISSN: 1476-4598 (Online)
Publisher: BMC
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://molecular-cancer.biomedcentral.com/